Circumvent

company

About

Circumvent is a biotech company

  • Portland,Oregon,United States
  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$4.09M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by NIH/NINDS, YC Bio, Heritage Provider Network, the Longevity Fund, and additional investors.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$7.93M
Circumvent has raised a total of $7.93M in funding over 2 rounds. Their latest funding was raised on Nov 1, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 1, 2021 Grant $303K Detail
Nov 1, 2021 Grant $495K Detail
Nov 1, 2021 Grant $2.89M Detail
Dec 9, 2020 Seed $4.09M 3 Detail
Mar 18, 2019 Pre-seed $150K 1 Y Combinator Detail

Investors

Number of Lead Investors
Number of Investors
1
4
Circumvent is funded by 4 investors. Y Combinator and DAYLI Financial Group are the most recent investors.
Investor Name Lead Investor Funding Round
Y Combinator Yes Pre-seed
DAYLI Financial Group Seed
Heritage Provider Network Seed
The Longevity Fund Seed

Employee Profiles

Number of Employee Profiles
4
Circumvent has 4 current employee profiles, including Executive Devin Wiley
Executive
Executive
Executive
Executive